Cover Image
Market Research Report

Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User - Global Forecast to 2022

Published by MarketsandMarkets Product code 299359
Published Content info 162 Pages
Immediate Delivery Available
Price
Back to Top
Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User - Global Forecast to 2022
Published: November 9, 2017 Content info: 162 Pages
Description

"Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period"

The tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics. On the other hand, complex regulatory frameworks that delay the approval of new diagnostic products and lack of infrastructure are expected to challenge market growth to a certain extent.

"The breast cancer segment is anticipated to grow at the fastest growth rate during the forecast period"

The tissue diagnostics market by disease, is categorized into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. The breast cancer segment is expected to grow at the highest CAGR during the forecast period. The growing use of tissue diagnostics for the diagnosis of breast cancer, increasing awareness regarding breast cancer, and the development of novel products are the key factor driving the growth of this market.

"The research laboratories segment is estimated to grow at a rapid rate during the analysis period"

By end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. The research laboratories segment is expected to remain the fastest-growing segment of the global tissue diagnostics market during the forecast period. Factors such as the rising number of cancer drug trials and growing research activities to design novel biomarkers for tissue diagnosis are driving the growth of this segment.

"Asia is estimated to grow at the highest CAGR during the study period"

Geographically, the tissue diagnostics market is dominated by North America, followed by Europe in 2017, however, Asia is estimated to grow at the fastest rate during the forecast period. Growth in this region can be attributed to developing healthcare infrastructure, rising burden of cancer, and increasing initiatives to promote the use of novel technologies for tissue diagnostics in Asian countries.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 70% and Tier 2 - 30%
  • By Designation - C level - 62%, Director level - 21%, Others - 17%
  • By Region - North America - 50%, Europe - 20%, Asia- 30%

The key players in the tissue diagnostics market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnostica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US).

Research Coverage:

The report analyses the tissue diagnostics market by product, technology, disease, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the tissue diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the tissue diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various tissue diagnostics products and services across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue diagnostics market
Table of Contents
Product Code: MD 2349

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. TISSUE DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: TISSUE DIAGNOSTICS MARKET IN ASIA, BY COUNTRY AND TECHNOLOGY
  • 4.3. GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE GLOBAL TISSUE DIAGNOSTICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising incidence of cancer
      • 5.2.1.2. Growing healthcare expenditure
      • 5.2.1.3. Improving infrastructure for cancer diagnosis
      • 5.2.1.4. Technological advancements in tissue diagnostics
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High degree of consolidation
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Growing demand for personalized medicine
      • 5.2.3.3. Rising number of clinical trials for cancer drugs
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Stringent regulatory requirements
      • 5.2.4.2. Lack of infrastructure and low awareness in middle- and low- income countries
    • 5.2.5. TRENDS
      • 5.2.5.1. Increasing number of reagent rental agreements

6. TISSUE DIAGNOSTICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. ANTIBODIES
    • 6.2.2. KITS
    • 6.2.3. REAGENTS
    • 6.2.4. PROBES
  • 6.3. INSTRUMENTS
    • 6.3.1. SLIDE-STAINING SYSTEMS
    • 6.3.2. SCANNERS
    • 6.3.3. TISSUE-PROCESSING SYSTEMS
    • 6.3.4. OTHER INSTRUMENTS

7. TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. IMMUNOHISTOCHEMISTRY (IHC)
  • 7.3. IN SITU HYBRIDIZATION (ISH)
  • 7.4. DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT
  • 7.5. SPECIAL STAINING

8. TISSUE DIAGNOSTICS MARKET, BY DISEASE

  • 8.1. INTRODUCTION
  • 8.2. BREAST CANCER
  • 8.3. GASTRIC CANCER
  • 8.4. LYMPHOMA
  • 8.5. PROSTATE CANCER
  • 8.6. NON-SMALL CELL LUNG CANCER (NSCLC)
  • 8.7. OTHER DISEASES

9. TISSUE DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS
  • 9.3. RESEARCH LABORATORIES
  • 9.4. PHARMACEUTICAL COMPANIES
  • 9.5. CONTRACT RESEARCH ORGANIZATIONS
  • 9.6. OTHER END USERS

10. TISSUE DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS

12. COMPANY PROFILES (Business Overview, Strength of product Portfolio, Business Strategy Excellence, Recent Developments,)*

  • 12.1. ROCHE
  • 12.2. DANAHER
  • 12.3. THERMO FISHER SCIENTIFIC
  • 12.4. ABBOTT
  • 12.5. AGILENT TECHNOLOGIES
  • 12.6. MERCK
  • 12.7. SAKURA FINETEK JAPAN
  • 12.8. ABCAM
  • 12.9. BD
  • 12.10. QIAGEN
  • 12.11. BIO SB
  • 12.12. BIOGENEX
  • 12.13. CELL SIGNALING TECHNOLOGY

*Details on Business Overview, Strength of product Portfolio, Business Strategy Excellence, Recent Developments, might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INDUSTRY INSIGHTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: TISSUE DIAGNOSTICS: MARKET SNAPSHOT
  • TABLE 2: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 3: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 4: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: TISSUE DIAGNOSTICS MARKET FOR ANTIBODIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: TISSUE DIAGNOSTICS MARKET FOR KITS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: TISSUE DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: TISSUE DIAGNOSTICS MARKET FOR PROBES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 10: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: TISSUE DIAGNOSTICS MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: TISSUE DIAGNOSTICS MARKET FOR SCANNERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: TISSUE DIAGNOSTICS MARKET FOR TISSUE-PROCESSING SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: TISSUE DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 16: TISSUE DIAGNOSTICS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: TISSUE DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: TISSUE DIAGNOSTICS MARKET FOR DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: TISSUE DIAGNOSTICS MARKET FOR SPECIAL STAINING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 21: TISSUE DIAGNOSTICS MARKET FOR BREAST CANCER, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: TISSUE DIAGNOSTICS MARKET FOR GASTRIC CANCER, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: TISSUE DIAGNOSTICS MARKET FOR LYMPHOMA, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: TISSUE DIAGNOSTICS MARKET FOR PROSTATE CANCER, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: TISSUE DIAGNOSTICS MARKET FOR NON-SMALL CELL LUNG CANCER, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: TISSUE DIAGNOSTICS MARKET FOR OTHER DISEASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 28: TISSUE DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: TISSUE DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: TISSUE DIAGNOSTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: TISSUE DIAGNOSTICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: TISSUE DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: TISSUE DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 37: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 39: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 41: US: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 42: US: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 43: US: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 44: CANADA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 45: CANADA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 46: CANADA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: EUROPE: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: EUROPE: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 53: EUROPE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 54: GERMANY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 55: GERMANY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 56: GERMANY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 57: UK: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 58: UK: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 59: UK: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: FRANCE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 61: FRANCE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 62: FRANCE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 63: ITALY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 64: ITALY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 65: ITALY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 66: SPAIN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: SPAIN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 68: SPAIN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 69: ROE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 70: ROE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 71: ROE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 73: ASIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 74: ASIA: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ASIA: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: ASIA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 77: ASIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 78: ASIA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: CHINA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 80: CHINA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: CHINA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 82: JAPAN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: JAPAN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 84: JAPAN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 85: INDIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 86: INDIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 87: INDIA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 88: ROA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 89: ROA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 90: ROA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 91: ROW: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 92: ROW: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 93: ROW: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 94: ROW: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 95: ROW: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 96: ROW: TISSUE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2017-2022 (USD BILLION)
  • FIGURE 7: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2022 (USD BILLION)
  • FIGURE 8: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2017-2022 (USD BILLION)
  • FIGURE 9: TISSUE DIAGNOSTICS MARKET, BY END USER, 2017-2022 (USD BILLION)
  • FIGURE 10: TISSUE DIAGNOSTICS MARKET, BY REGION, 2017-2022 (USD BILLION)
  • FIGURE 11: RISING INCIDENCE OF CANCER TO DRIVE THE GROWTH OF THE TISSUE DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: IMMUNOHISTOCHEMISTRY TO DOMINATE THE TISSUE DIAGNOSTICS MARKET IN ASIA IN 2017
  • FIGURE 13: RESEARCH LABORATORIES WILL REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: TISSUE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
  • FIGURE 16: GLOBAL HEALTHCARE SPENDING, 2004-2014
  • FIGURE 17: GROWTH IN PER CAPITA HEALTHCARE EXPENDITURE IN BRICS COUNTRIES, 2004-2014
  • FIGURE 18: CONSUMABLES SEGMENT TO DOMINATE THE GLOBAL TISSUE DIAGNOSTICS PRODUCTS MARKET IN 2017
  • FIGURE 19: IMMUNOHISTOCHEMISTRY TO DOMINATE THE TISSUE DIAGNOSTICS TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 21: GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 22: TISSUE DIAGNOSTICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 23: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 24: CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD
  • FIGURE 25: EUROPE: TISSUE DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 26: BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN EUROPE IN 2017
  • FIGURE 27: ASIA: TISSUE DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 28: IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ASIA IN 2017
  • FIGURE 29: ROW: TISSUE DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 30: HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2017
  • FIGURE 31: TISSUE DIAGNOSTICS MARKET: MARKET SHARE (2016)
  • FIGURE 32: ROCHE: COMPANY SNAPSHOT
  • FIGURE 33: DANAHER: COMPANY SNAPSHOT
  • FIGURE 34: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 35: ABBOTT: COMPANY SNAPSHOT
  • FIGURE 36: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
  • FIGURE 37: MERCK: COMPANY SNAPSHOT
  • FIGURE 38: ABCAM: COMPANY SNAPSHOT
  • FIGURE 39: BD: COMPANY SNAPSHOT
  • FIGURE 40: QIAGEN : COMPANY SNAPSHOT
Back to Top